Tenon Medical Statistics
Total Valuation
Tenon Medical has a market cap or net worth of $2.61 million. The enterprise value is $6.61 million.
| Market Cap | 2.61M |
| Enterprise Value | 6.61M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Tenon Medical has 667,047 shares outstanding. The number of shares has increased by 169.77% in one year.
| Current Share Class | 667,047 |
| Shares Outstanding | 667,047 |
| Shares Change (YoY) | +169.77% |
| Shares Change (QoQ) | +1.88% |
| Owned by Insiders (%) | 4.84% |
| Owned by Institutions (%) | 6.16% |
| Float | 620,827 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.64 |
| Forward PS | 0.52 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.58
| Current Ratio | 0.58 |
| Quick Ratio | 0.44 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.78 |
Financial Efficiency
Return on equity (ROE) is -551.19% and return on invested capital (ROIC) is -138.43%.
| Return on Equity (ROE) | -551.19% |
| Return on Assets (ROA) | -71.98% |
| Return on Invested Capital (ROIC) | -138.43% |
| Return on Capital Employed (ROCE) | -749.10% |
| Weighted Average Cost of Capital (WACC) | 13.35% |
| Revenue Per Employee | $204,308 |
| Profits Per Employee | -$526,808 |
| Employee Count | 26 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.40 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.29% in the last 52 weeks. The beta is 1.36, so Tenon Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.36 |
| 52-Week Price Change | -90.29% |
| 50-Day Moving Average | 6.06 |
| 200-Day Moving Average | 22.52 |
| Relative Strength Index (RSI) | 42.60 |
| Average Volume (20 Days) | 16,415,453 |
Short Selling Information
The latest short interest is 130,094, so 19.50% of the outstanding shares have been sold short.
| Short Interest | 130,094 |
| Short Previous Month | 8,042 |
| Short % of Shares Out | 19.50% |
| Short % of Float | 20.95% |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, Tenon Medical had revenue of $5.31 million and -$13.70 million in losses. Loss per share was -$46.67.
| Revenue | 5.31M |
| Gross Profit | 3.55M |
| Operating Income | -12.11M |
| Pretax Income | -13.70M |
| Net Income | -13.70M |
| EBITDA | -11.80M |
| EBIT | -12.11M |
| Loss Per Share | -$46.67 |
Balance Sheet
The company has $1.68 million in cash and $5.68 million in debt, with a net cash position of -$4.00 million or -$6.00 per share.
| Cash & Cash Equivalents | 1.68M |
| Total Debt | 5.68M |
| Net Cash | -4.00M |
| Net Cash Per Share | -$6.00 |
| Equity (Book Value) | -1.74M |
| Book Value Per Share | -14.57 |
| Working Capital | -3.50M |
Cash Flow
In the last 12 months, operating cash flow was -$11.77 million and capital expenditures -$1.06 million, giving a free cash flow of -$12.83 million.
| Operating Cash Flow | -11.77M |
| Capital Expenditures | -1.06M |
| Depreciation & Amortization | 315,000 |
| Net Borrowing | 4.30M |
| Free Cash Flow | -12.83M |
| FCF Per Share | -$19.23 |
Margins
Gross margin is 66.81%, with operating and profit margins of -228.03% and -257.85%.
| Gross Margin | 66.81% |
| Operating Margin | -228.03% |
| Pretax Margin | -257.85% |
| Profit Margin | -257.85% |
| EBITDA Margin | -222.10% |
| EBIT Margin | -228.03% |
| FCF Margin | n/a |
Dividends & Yields
Tenon Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -169.77% |
| Shareholder Yield | -169.77% |
| Earnings Yield | -405.81% |
| FCF Yield | -379.97% |
Analyst Forecast
The average price target for Tenon Medical is $44.38, which is 1,035.04% higher than the current price. The consensus rating is "Buy".
| Price Target | $44.38 |
| Price Target Difference | 1,035.04% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 71.81% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 10, 2026. It was a reverse split with a ratio of 1:35.
| Last Split Date | Aug 10, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
Tenon Medical has an Altman Z-Score of -15.96 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.96 |
| Piotroski F-Score | 3 |